Director of Communications, University of Michigan Rogel Cancer
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.


Health Lab
A study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments.

Health Lab
As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a recent study sheds light on whether patients are opting for it.

Health Lab
University of Michigan Health Rogel Cancer Center scientists identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an existing class of drugs, suggesting a potential treatment strategy for patients with aggressive subtypes of prostate cancer.

Medicine at Michigan
Susan and Richard Rogel have given $50 million to create the Rogel and Blondy Center for Pancreatic Cancer at Michigan Medicine.

Health Lab
Research by the University of Michigan Health Rogel Cancer Center finds that patients with three of these variants face no extra risk of dying from their cancer.

Health Lab
A specialist outlines some recent advances that have him excited for the future of multiple myeloma treatment.

Health Lab
The first large scale analysis finds immune checkpoint inhibitors are equally effective in Black and white patients, with Black patients having fewer side effects.

Health Lab
New research has discovered why some cancers don’t respond to immunotherapy treatment: A metabolite transporter within the tumor microenvironment blocks a key type of tumor cell death integral to immune response.

News Release
New Rogel and Blondy Center for Pancreatic Cancer will bring together researchers and clinicians to drive forward new treatments and improve outcomes

Health Lab
In two separate papers, U-M researchers describe how a gene alteration drives prostate cancer and a potential degrader that stops it

Health Lab
Researchers have developed a new model to help predict treatment response in patients with bladder cancer.

Health Lab
A study finds that efforts to cap prescription drug spending are yielding significant out-of-pocket savings for these patients.

Health Lab
Researchers have uncovered a key reason why a typically normal protein goes awry and fuels cancer. They found the protein NSD2 alters the function of the androgen receptor, an important regulator of normal prostate development.

Health Lab
As cancer treatment and survivorship care relies more on understanding the genetic make up of an individual’s tumor, a study from the University of Michigan Health Rogel Cancer Center finds that many breast cancer survivors who meet criteria for genetic counseling and testing are not receiving it.

Health Lab
Researchers find common immune system mechanism between pregnancy, cancer